NewAmsterdam Pharma Company N.V. (NAMS)
(Delayed Data from NSDQ)
$19.59 USD
-0.04 (-0.20%)
Updated Jun 25, 2024 10:08 AM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | -0.59 |
EPS Last Quarter | -0.62 |
Last EPS Surprise | -14.81% |
ABR | 1.13 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.52 |
Next Year | -1.60 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.20M | 5.35M | 9.97M | 9.90M |
# of Estimates | 2 | 2 | 3 | 1 |
High Estimate | 3.30M | 8.70M | 22.00M | 9.90M |
Low Estimate | 1.10M | 2.00M | 2.50M | 9.90M |
Year ago Sales | NA | NA | 14.09M | 9.97M |
Year over Year Growth Est. | NA | NA | -29.26% | -0.67% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.59 | -0.51 | -2.52 | -1.60 |
# of Estimates | 5 | 4 | 5 | 5 |
Most Recent Consensus | -0.58 | -0.49 | -2.33 | -1.59 |
High Estimate | -0.51 | -0.44 | -1.92 | -1.17 |
Low Estimate | -0.65 | -0.54 | -2.74 | -1.90 |
Year ago EPS | NA | NA | -2.15 | -2.52 |
Year over Year Growth Est. | NA | NA | -17.21% | 36.43% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 3 | 4 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.59 | -0.51 | -2.52 | -1.60 |
7 Days Ago | -0.59 | -0.51 | -2.52 | -1.60 |
30 Days Ago | -0.59 | -0.51 | -2.52 | -1.60 |
60 Days Ago | -0.54 | -0.45 | -1.89 | -1.26 |
90 Days Ago | -0.54 | -0.45 | -1.89 | -1.26 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.59 | -0.51 | -2.52 | -1.60 |
Zacks Consensus Estimate | -0.59 | -0.51 | -2.52 | -1.60 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.62 | NA | NA | NA | NA |
Estimate | -0.54 | NA | NA | NA | NA |
Difference | -0.08 | NA | NA | NA | -0.08 |
Surprise | -14.81% | NA | NA | NA | -14.81% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more